JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report)’s share price was up 5.2% during mid-day trading on Thursday . The stock traded as high as $3.31 and last traded at $3.31. 476 shares changed hands during trading, a decline of 5% from the average session volume of 500 shares. The stock had previously closed at $3.1450.
JCR Pharmaceuticals Price Performance
The stock’s 50 day simple moving average is $3.66 and its 200 day simple moving average is $4.11.
About JCR Pharmaceuticals
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
Featured Articles
- Five stocks we like better than JCR Pharmaceuticals
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential
- MarketBeat Week in Review – 06/29 – 07/03
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
